Nonalcoholic fatty liver disease.
Explore this paper's citation graph
Summary
Nonalcoholic fatty liver disease is associated with an increased risk of all-cause death, probably because of complications of insulin resistance such as vascular disease, as well as due to cirrhosis and hepatocellular carcinoma, which occurs in a minority of patients.
- Type
- review
- Published
- 2002-04-18
- Cited by
- 2,406
- References
- 104
- OpenAlex
- https://openalex.org/W2040109162
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:413224
Keywords
Fatty liver, Cirrhosis, Medicine, Steatosis, Steatohepatitis
References
- Metformin in non-alcoholic steatohepatitis.
- Non‐alcoholic steatohepatitis in children and adolescents
- Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.
- Nonalcoholic fatty liver disease.
- High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
- Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population)
- Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
- Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?
- GI Epidemiology: nonalcoholic fatty liver disease
- The lipid peroxidation end product 4‐hydroxy‐2,3‐nonenal up‐regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis 1
- Fatty Infiltration of Liver in Hyperlipidemic Patients
- Effect of weight reduction on hepatic abnormalities in overweight patients.
- Overweight and obesity in the United States: prevalence and trends, 1960–1994
- Fatty liver hepatitis and cirrhosis in obese patients.
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes
- Persistent hyperaminotransferasemia resolving after weight reduction in obese children.
- Idiopathic steatohepatitis in childhood: a multicenter retrospective study.
- Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
- Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.
- Focal manifestations of diffuse liver disease at MR imaging.
Cited by
- Antiretroviral-associated liver injury.
- Etiological features of cirrhosis inpatients in Beijing, China
- Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia.
- Lipid metabolism in hepatic steatosis.
- Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: new treatment for global dangers.
- Identification of a novel single-stranded DNA fragment associated with human hepatitis.
- Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver disease
- Pathogenesis of non-alcoholic steatohepatitis: human data.
- Steatosis hepatis – eine Herausforderung?
- Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease
- Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.
- Liver HCV-antigens and steatosis in chronic hepatitis C: role of different genotypes.
- Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease.
- Exercise training increases hepatic endoplasmic reticulum (er) stress protein expression in MTP‐inhibited high‐fat fed rats
- Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension
- Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
- Clinical features and risk factors of patients with fatty liver in Guangzhou area.
- Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis
- Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
- PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Related papers
- Rapid Decrease in Liver Graft Steatosis in the Early Post-transplant Period: A Blinded and Randomized Study.
- Clinical significance analysis of peripheral blood levels of soluble CD147 detection for patients with hyperlipidemia
- Study on risk factors of hyperlipidemia
- Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
- STUDY OF CELL MODELS OF HEPG2 STEATOSIS AND STEATOHEPATITIS VIABILITY
- Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis
- 1232 XANTHOHUMOL IMPROVES GLUCOSE TOLERANCE AND INHIBITS HEPATIC STEATOSIS, INFLAMMATION AND FIBROGENESIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS